Leigh Naylor-Adamson
Quantum Dot Imaging Agents: Haematopoietic Cell Interactions and Biocompatibility
Naylor-Adamson, Leigh; Price, Thomas W.; Booth, Zoe; Stasiuk, Graeme J.; Calaminus, Simon D.J.
Authors
Thomas W. Price
Zoe Booth
Graeme J. Stasiuk
Dr Simon Calaminus S.Calaminus@hull.ac.uk
Senior Lecturer
Abstract
Quantum dots (QDs) are semi-conducting nanoparticles that have been developed for a range of biological and non-biological functions. They can be tuned to multiple different emission wavelengths and can have significant benefits over other fluorescent systems. Many studies have utilised QDs with a cadmium-based core; however, these QDs have since been shown to have poor biological compatibility. Therefore, other QDs, such as indium phosphide QDs, have been developed. These QDs retain excellent fluorescent intensity and tunability but are thought to have elevated biological compatibility. Herein we discuss the applicability of a range of QDs to the cardiovascular system. Key disease states such as myocardial infarction and stroke are associated with cardiovascular disease (CVD), and there is an opportunity to improve clinical imaging to aide clinical outcomes for these disease states. QDs offer potential clinical benefits given their ability to perform multiple functions, such as carry an imaging agent, a therapy, and a targeting motif. Two key cell types associated with CVD are platelets and immune cells. Both cell types play key roles in establishing an inflammatory environment within CVD, and as such aid the formation of pathological thrombi. However, it is unclear at present how and with which cell types QDs interact, and if they potentially drive unwanted changes or activation of these cell types. Therefore, although QDs show great promise for boosting imaging capability, further work needs to be completed to fully understand their biological compatibility.
Citation
Naylor-Adamson, L., Price, T. W., Booth, Z., Stasiuk, G. J., & Calaminus, S. D. (2024). Quantum Dot Imaging Agents: Haematopoietic Cell Interactions and Biocompatibility. Cells, 13(4), Article 354. https://doi.org/10.3390/cells13040354
Journal Article Type | Review |
---|---|
Acceptance Date | Feb 13, 2024 |
Online Publication Date | Feb 18, 2024 |
Publication Date | Feb 2, 2024 |
Deposit Date | Mar 13, 2024 |
Publicly Available Date | Mar 13, 2024 |
Journal | Cells |
Electronic ISSN | 2073-4409 |
Publisher | MDPI |
Peer Reviewed | Peer Reviewed |
Volume | 13 |
Issue | 4 |
Article Number | 354 |
DOI | https://doi.org/10.3390/cells13040354 |
Keywords | Quantum dots; Cardiovascular diseases; Imaging |
Public URL | https://hull-repository.worktribe.com/output/4577785 |
Files
Published article
(1.6 Mb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0
Copyright Statement
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
You might also like
Practical considerations of dissolved oxygen levels for platelet function under hypoxia
(2021)
Journal Article
Platelet zinc status regulates prostaglandin-induced signaling, altering thrombus formation
(2023)
Journal Article
Impact of Surface Ligand on the Biocompatibility of InP/ZnS Quantum Dots with Platelets
(2023)
Journal Article
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search